Early diagnosis of central nervous system involvement of malignant lymphoma by multiplex PCR method

Early diagnosis of central nervous system involvement of malignant lymphoma by multiplex PCR method - Early diagnosis of central nervous system involvement of malignant lymphoma

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004521

Enrollment

Registered

2010-11-10

Start date

2011-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignant Lymphoma

Interventions

Central nervous system-targeted therapy in patients with IgH gene rearrangement Standard therapy (R-CHOP therapy) in patients without IgH rearrangement

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Untreated patients with malignant lymphoma

Exclusion criteria

Exclusion criteria: Patients without informed consent

Design outcomes

Primary

Measure	Time frame
Detection of IgH gene rearrangement	—

Secondary

Measure	Time frame
effect of therapy	—

Countries

Japan

Contacts

Public ContactNaoto Tomita

Yokohama City University Graduate School of Medicine Internal Medicine and Clinical Immunology

cavalier@ch-yamate.dlenet.com045-787-2800

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026